肝动脉栓塞治疗肝癌疗效分析

Analysis of Therapeutic Effect of Hepatic Arterial Embolization on Hepatic Carcinoma

对92例肝癌患者经肝动脉化疗栓塞术进行随访,1年和2年生存率分别为60.9％和30.4％。肝动脉栓塞治疗肝癌的疗效同患者能接受的治疗方式,术前肝功能和肿瘤生长类型有关,Lp—TAE+GS是首选的治疗方式,富血癌灶且肝功能为Child'sA级是TAE的主要对象,单结节膨胀型者疗效好。早期诊治是TAE成功的关键,努力改善肝功能是TAE的重要措施。

92 cases of hepatic carcinoma were treated with hepatic arterial emboliza-tion. A follow-up survey showed that one and two year survival rates were 60. 9% and 30. 4% respectively. The therapeutic effect was related to such factors as patient-accepted treatments, preoperative liver function and the growth types of hepatic carcinoma. LP-TAE + GS was the first treatment choice. The subjects of TAE were mainly those of foci with sufficient blood supply and Child's A grade liver function. Satisfactory effects were observed a-mong the cases with single nodes of expansive type. It is indicated in this paper that the success of TAE depends on the early diagnosis and treatment,and that great efforts have to be made to improve the liver function in the course of treatments.